- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/726 - Glycosaminoglycans, i.e. mucopolysaccharides
Patent holdings for IPC class A61K 31/726
Total number of patents in this class: 418
10-year publication summary
|
35
|
40
|
36
|
42
|
18
|
29
|
29
|
22
|
18
|
22
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Synedgen, Inc. | 60 |
18 |
| Seikagaku Corporation | 185 |
9 |
| The University of North Carolina at Chapel Hill | 2057 |
7 |
| The Regents of the University of California | 20108 |
6 |
| Exthera Medical Corporation | 55 |
6 |
| Jiuzhitang Co., Ltd. | 18 |
5 |
| Rohto Pharmaceutical Co., Ltd. | 387 |
5 |
| Société des Produits Nestlé S.A. | 9330 |
4 |
| Centre National de La Recherche Scientifique | 10564 |
4 |
| Altergon S.A. | 94 |
4 |
| Bausch & Lomb Incorporated | 1104 |
4 |
| Ibsa Institut Biochimique S.A. | 295 |
4 |
| Laboratorios Farmaceuticos Rovi, S.A. | 239 |
4 |
| Maruho Co., Ltd. | 94 |
4 |
| U.S. Nutraceuticals, L.L.C., DBA Valensa International | 27 |
4 |
| Glycologix, Inc. | 6 |
4 |
| Notogen, Inc. | 5 |
4 |
| Corvivo Cardiovascular, Inc. | 100 |
4 |
| Agency for Science, Technology and Research | 3658 |
3 |
| Duke University | 3090 |
3 |
| Other owners | 312 |